Assay ID | Title | Year | Journal | Article |
AID464196 | Cytotoxicity against vincristine-resistant human KB/VJ300 cells in presence of 0.1 ug/ml vincristine | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12
| Leuconicines A-G and (-)-eburnamaline, biologically active strychnan and eburnan alkaloids from Leuconotis. |
AID1064669 | Cytotoxicity against human KB cells overexpressing human MDR1 assessed as reduction in cell viability after 4 days by MTT assay | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. |
AID1329361 | Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth microdilution method | 2016 | Journal of natural products, 09-23, Volume: 79, Issue:9
| Melokhanines A-J, Bioactive Monoterpenoid Indole Alkaloids with Diverse Skeletons from Melodinus khasianus. |
AID1064666 | Inhibition of p-glycoprotein (unknown origin) overexpressed in human KBV20C cells assessed as potentiation of vincristine-induced cytotoxicity at 3 uM incubated for 1 hr prior to vincristine challenge measured after 4 days by MTT assay | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. |
AID464432 | Cytotoxic activity against human HL60 cells after 48 hrs by MTT assay | 2010 | Journal of natural products, Jan, Volume: 73, Issue:1
| Melodinines A-G, monoterpenoid indole alkaloids from Melodinus henryi. |
AID1064668 | Cytotoxicity against human KBV20C cells overexpressing pgp assessed as reduction in cell viability after 4 days by MTT assay | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. |
AID464434 | Cytotoxic activity against human A549 cells after 48 hrs by MTT assay | 2010 | Journal of natural products, Jan, Volume: 73, Issue:1
| Melodinines A-G, monoterpenoid indole alkaloids from Melodinus henryi. |
AID464195 | Cytotoxicity against vincristine-resistant human KB/VJ300 cells | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12
| Leuconicines A-G and (-)-eburnamaline, biologically active strychnan and eburnan alkaloids from Leuconotis. |
AID464435 | Cytotoxic activity against human SK-BR-3 cells after 48 hrs by MTT assay | 2010 | Journal of natural products, Jan, Volume: 73, Issue:1
| Melodinines A-G, monoterpenoid indole alkaloids from Melodinus henryi. |
AID1064661 | Inhibition of human MDR1 overexpressed in human KB cells assessed as potentiation of vincristine-induced cytotoxicity at 3 uM incubated for 1 hr prior to vincristine challenge measured after 4 days by MTT assay relative to verapamil | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. |
AID464194 | Cytotoxicity against vincristine-sensitive human KB cells | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12
| Leuconicines A-G and (-)-eburnamaline, biologically active strychnan and eburnan alkaloids from Leuconotis. |
AID1329362 | Antibacterial activity against Enterococcus faecalis ATCC 10541 after 24 hrs by broth microdilution method | 2016 | Journal of natural products, 09-23, Volume: 79, Issue:9
| Melokhanines A-J, Bioactive Monoterpenoid Indole Alkaloids with Diverse Skeletons from Melodinus khasianus. |
AID1064673 | Binding affinity to p-glycoprotein (unknown origin) by intrinsic tryptophan fluorescence quenching assay | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. |
AID1064667 | Inhibition of p-glycoprotein (unknown origin) overexpressed in human KBV20C cells assessed as potentiation of vincristine-induced cytotoxicity at 1 uM incubated for 1 hr prior to vincristine challenge measured after 4 days by MTT assay | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. |
AID1064662 | Inhibition of human MDR1 overexpressed in human KB cells assessed as potentiation of vincristine-induced cytotoxicity at 1 uM incubated for 1 hr prior to vincristine challenge measured after 4 days by MTT assay relative to verapamil | 2014 | Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
| Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. |
AID1329364 | Antibacterial activity against Staphylococcus aureus ATCC 25922 after 24 hrs by broth microdilution method | 2016 | Journal of natural products, 09-23, Volume: 79, Issue:9
| Melokhanines A-J, Bioactive Monoterpenoid Indole Alkaloids with Diverse Skeletons from Melodinus khasianus. |
AID464433 | Cytotoxic activity against human SMMC7721 cells after 48 hrs by MTT assay | 2010 | Journal of natural products, Jan, Volume: 73, Issue:1
| Melodinines A-G, monoterpenoid indole alkaloids from Melodinus henryi. |
AID464197 | Cytotoxicity against vincristine-resistant human KB/VJ300 cells in presence of 0.121 uM vincristine | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12
| Leuconicines A-G and (-)-eburnamaline, biologically active strychnan and eburnan alkaloids from Leuconotis. |
AID1329365 | Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 24 hrs by broth microdilution method | 2016 | Journal of natural products, 09-23, Volume: 79, Issue:9
| Melokhanines A-J, Bioactive Monoterpenoid Indole Alkaloids with Diverse Skeletons from Melodinus khasianus. |
AID1329363 | Antibacterial activity against Escherichia coli ATCC 11775 after 24 hrs by broth microdilution method | 2016 | Journal of natural products, 09-23, Volume: 79, Issue:9
| Melokhanines A-J, Bioactive Monoterpenoid Indole Alkaloids with Diverse Skeletons from Melodinus khasianus. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |